Showing 1 - 10 of 976
The following is a model of psychological contracting with unmonitorable performance, implicit offers, and screening for non-performance by the announcement of the expectation of performance. It is motivated by the $250 billion prescription drug industry, which spends $19 billion per year on...
Persistent link: https://www.econbiz.de/10015217994
The following is a model of psychological contracting with unmonitorable performance, implicit offers, and screening for non-performance by the announcement of the expectation of performance. It is motivated by the $250 billion prescription drug industry, which spends $19 billion per year on...
Persistent link: https://www.econbiz.de/10015218020
The following is a model of psychological contracting with unmonitorable performance, implicit offers, and screening for non-performance by the announcement of the expectation of performance. It is motivated by the $250 billion prescription drug industry, which spends $19 billion per year on...
Persistent link: https://www.econbiz.de/10015219808
Gifts are often used where the institutions of contracting do not exist, or are underdeveloped, as in emerging markets, or otherwise unenforceable, as with illicit transactions in developed markets. The following is an analysis of gifts in the context of belief preferences with unobservable...
Persistent link: https://www.econbiz.de/10015229619
We develop a structural model of detailing and prescribing decisions under an environment where detailing helps physicians obtain the current information sets about drug qualities. Our model assumes that a representative opinion leader is responsible for updating the prior belief about the...
Persistent link: https://www.econbiz.de/10015258589
A fundamental question in pharmaceutical marketing management is: How does the effectiveness of detailing change when additional information on drugs is revealed via patients' experiences during the product lifecycle? To address this question, we develop a model of detailing and prescribing...
Persistent link: https://www.econbiz.de/10015238477
Public insurers face trade-offs between the individual and collective benefits they can provide given limited resources. Drug expenditure is one of the largest components of health spending and it is not clear cut what should be readily available. We study litigation as a safety valve using data...
Persistent link: https://www.econbiz.de/10015213274
The following article analyses the relationship between the mental health index and the variables of the Environment, Social and Governance-ESG model in the Italian regions between 2004 and 2023. The econometric analysis is aimed at investigating in detail the relationships between the mental...
Persistent link: https://www.econbiz.de/10015213592
The following article analyses the relationship between the mental health index and the variables of the Environment, Social and Governance-ESG model in the Italian regions between 2004 and 2023. First of all, a static analysis is proposed aimed at identifying trends relating to mental health in...
Persistent link: https://www.econbiz.de/10015213593
Japan’s national hospital system, which consists of a combination of private, national, prefectural and metropolitan hospitals, is the largest employers of the of the doctors. The article provides details on the women doctors’ discontinuous workforce participation in the Japanese hospital...
Persistent link: https://www.econbiz.de/10015214848